本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

17.18
-1.6200-8.62%
成交量:52.89萬
成交額:945.18萬
市值:6.38億
市盈率:-2.32
高:19.26
開:18.87
低:17.09
收:18.80
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:1.89
換手率:3.32%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:8.80
市盈率(LYR):-1.34

資料載入中...

2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/15

重要事件披露

Form 8-K - Current report
2026/07/14

重要事件披露

Form 8-K - Current report
2026/06/22

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/14

SEC問詢函

Form CORRESP - Correspondence
2026/01/07

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/12/04

重要事件披露

Form 8-K - Current report
2025/11/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans